Alison T Stopeck

  • 10991 Citations
  • 41 h-Index
1982 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2012

Task-based evaluation of segmentation algorithms for diffusion-weighted MRI without using a gold standard

Jha, A. K., Kupinski, M. A., Rodriguez, J. J., Stephen, R. M. & Stopeck, A. T., Jul 7 2012, In : Physics in Medicine and Biology. 57, 13, p. 4425-4446 22 p.

Research output: Contribution to journalArticle

12 Scopus citations

The role of targeted therapy and biomarkers in breast cancer treatment

Stopeck, A. T., Brown-Glaberman, U., Wong, H. Y., Park, B. H., Barnato, S. E., Gradishar, W. J., Hudis, C. A. & Rugo, H. S., Oct 2012, In : Clinical and Experimental Metastasis. 29, 7, p. 807-819 13 p.

Research output: Contribution to journalArticle

29 Scopus citations

Weighing bone-targeted treatment options for patients with solid tumours and skeletal complications from metastatic disease

Fallowfield, L., von Moos, R., Costa, L., Stopeck, A. T., Clemons, M., Clarke, N., Braun, A. & Chung, K., Jul 2012, In : European Oncology and Haematology. 8, 3, p. 148-155 8 p.

Research output: Contribution to journalArticle

3 Scopus citations
2011

Decreased bone mineral density in adult patients with Hemophilia: Clinical significance, prevalence and risk factors

Broum-Glaberman, U., Kissee, M. C., Damiano, M. L., Roe, D. & Stopeck, A. T., Oct 2011, In : Journal of Coagulation Disorders. 3, 1, p. 27-33 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?

Gralow, J. R., Lipton, A. & Stopeck, A. T., Sep 10 2011, In : Journal of Clinical Oncology. 29, 26, p. 3591-3592 2 p.

Research output: Contribution to journalArticle

2 Scopus citations

HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab

Modi, S., Stopeck, A. T., Linden, H., Solit, D., Chandarlapaty, S., Rosen, N., D'Andrea, G., Dickler, M., Moynahan, M. E., Sugarman, S., Ma, W., Patil, S., Norton, L., Hannah, A. L. & Hudis, C., Aug 1 2011, In : Clinical Cancer Research. 17, 15, p. 5132-5139 8 p.

Research output: Contribution to journalArticle

287 Scopus citations

Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors

Gerber, D. E., Stopeck, A. T., Wong, L., Rosen, L. S., Thorpe, P. E., Shan, J. S. & Ibrahim, N. K., Nov 1 2011, In : Clinical Cancer Research. 17, 21, p. 6888-6896 9 p.

Research output: Contribution to journalArticle

45 Scopus citations

Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer

Rugo, H. S., Stopeck, A. T., Joy, A. A., Chan, S., Verma, S., Lluch, A., Liau, K. F., Kim, S., Bycott, P., Rosbrook, B., Bair, A. H. & Soulieres, D., Jun 20 2011, In : Journal of Clinical Oncology. 29, 18, p. 2459-2465 7 p.

Research output: Contribution to journalArticle

86 Scopus citations

Reply to M.S. Aapro

Stopeck, A. T., Lipton, A., Body, J. J., Steger, G. G., Tonkin, K., De Boer, R. H., Fujiwara, Y., Yardley, D. A., Viniegra, M., Fan, M., Jiang, Q., Dansey, R., Jun, S. & Braun, A., May 10 2011, In : Journal of Clinical Oncology. 29, 14

Research output: Contribution to journalArticle

1 Scopus citations

Reply to V. Fusco et al

Stopeck, A. T., Lipton, A., Body, J. J., Steger, G. G., Tonkin, K., De Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., Fan, M., Jiang, Q., Dansey, R., Jun, S. & Braun, A., Jun 10 2011, In : Journal of Clinical Oncology. 29, 17

Research output: Contribution to journalArticle

4 Scopus citations

Systemic treatment of early breast cancer - A biological perspective

Greenberg, S., Stopeck, A. T. & Rugo, H. S., May 1 2011, In : Journal of Surgical Oncology. 103, 6, p. 619-626 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

The reply

Chalasani, P. & Stopeck, A. T., Feb 2011, In : American Journal of Medicine. 124, 2

Research output: Contribution to journalArticle

2010
14 Scopus citations

A clustering algorithm for liver lesion segmentation of diffusion-weighted MR images

Jha, A. K., Rodriguez, J. J., Stephen, R. M. & Stopeck, A. T., 2010, Proceedings of the IEEE Southwest Symposium on Image Analysis and Interpretation. p. 93-96 4 p. 5483911

Research output: Chapter in Book/Report/Conference proceedingConference contribution

15 Scopus citations

ADC estimation in multi-scan DWMRI

Jha, A. K., Kupinski, M. A., Rodriguez, J. J., Stephen, R. M. & Stopeck, A. T., 2010, Optics InfoBase Conference Papers.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

ADC estimation of lesions in diffusion-weighted MR images: A maximum-likelihood approach

Jha, A. K., Kupinski, M. A., Rodriguez, J. J., Stephen, R. M. & Stopeck, A. T., 2010, Proceedings of the IEEE Southwest Symposium on Image Analysis and Interpretation. p. 209-212 4 p. 5483880

Research output: Chapter in Book/Report/Conference proceedingConference contribution

4 Scopus citations
11 Scopus citations

Caring for the Breast Cancer Survivor: A Guide for Primary Care Physicians

Chalasani, P., Downey, L. & Stopeck, A. T., Jun 2010, In : American Journal of Medicine. 123, 6, p. 489-495 7 p.

Research output: Contribution to journalArticle

24 Scopus citations

Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets

Thomson, C., Stopeck, A. T., Bea, J. W., Cussler, E., Nardi, E., Frey, G. & Thompson, P. A., Nov 2010, In : Nutrition and Cancer. 62, 8, p. 1142-1152 11 p.

Research output: Contribution to journalArticle

43 Scopus citations

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study

Stopeck, A. T., Lipton, A., Body, J. J., Steger, G. G., Tonkin, K., De Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., Fan, M., Jiang, Q., Dansey, R., Jun, S. & Braun, A., Dec 10 2010, In : Journal of Clinical Oncology. 28, 35, p. 5132-5139 8 p.

Research output: Contribution to journalArticle

978 Scopus citations

Evaluating segmentation algorithms for diffusion-weighted MR images: A task-based approach

Jha, A. K., Kupinski, M. A., Rodriguez, J. J., Stephen, R. M. & Stopeck, A. T., 2010, Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7627. 76270L

Research output: Chapter in Book/Report/Conference proceedingConference contribution

8 Scopus citations

Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I Trial

Thompson, P. A., Hsu, C-H., Green, S., Stopeck, A. T., Johnson, K., Alberts, D. S. & Chow, H-H., Jan 2010, In : Cancer Prevention Research. 3, 1, p. 101-107 7 p.

Research output: Contribution to journalArticle

5 Scopus citations
2009

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

Stopeck, A. T., Unger, J. M., Rimsza, L. M., Bellamy, W. T., Iannone, M. E., Persky, D., Leblanc, M., Fisher, R. & Miller, T. P., 2009, In : Leukemia and Lymphoma. 50, 5, p. 728-735 8 p.

Research output: Contribution to journalArticle

82 Scopus citations

Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.

Thomson, C., Thompson, P. A., Bea, J. W., Nardi, E., Frey, G. R. & Stopeck, A. T., Dec 2009, In : Journal of Women's Health. 18, 12, p. 2041-2047 7 p.

Research output: Contribution to journalArticle

41 Scopus citations

Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia

Gerstner, G., Damiano, M. L., Tom, A., Worman, C., Schultz, W., Recht, M. & Stopeck, A. T., 2009, In : Haemophilia. 15, 2, p. 559-565 7 p.

Research output: Contribution to journalArticle

76 Scopus citations
2008

A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer

Gordon, M. S., Mendelson, D., Carr, R., Knight, R. A., Humerickhouse, R. A., Iannone, M. E. & Stopeck, A. T., Dec 15 2008, In : Cancer. 113, 12, p. 3420-3429 10 p.

Research output: Contribution to journalArticle

21 Scopus citations

Hepatic injury associated with bevacizumab use in metastatic breast and colon cancers: A review of two cases

Brown-Glaberman, U., Swart, R., Dragovich, T., Bracamonte, E., Kurtin, S. & Stopeck, A. T., Oct 2008, In : Community Oncology. 5, 10, p. 539-542 4 p.

Research output: Contribution to journalArticle

7 Scopus citations
2007

Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I dose-escalation study

Modi, S., Stopeck, A. T., Gordon, M. S., Mendelson, D., Solit, D. B., Bagatell, R., Ma, W., Wheler, J., Rosen, N., Norton, L., Cropp, G. F., Johnson, R. G., Hannah, A. L. & Hudis, C. A., Dec 1 2007, In : Journal of Clinical Oncology. 25, 34, p. 5410-5417 8 p.

Research output: Contribution to journalArticle

285 Scopus citations

Diagnosing and treating breast cancer in elderly women: A call for improved understanding

Downey, L., Livingston, R. B. & Stopeck, A. T., Oct 2007, In : Journal of the American Geriatrics Society. 55, 10, p. 1636-1644 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

DeAngelo, D. J., Yu, D., Johnson, J. L., Coutre, S. E., Stone, R. M., Stopeck, A. T., Gockerman, J. P., Mitchell, B. S., Appelbaum, F. R. & Larson, R. A., Jun 15 2007, In : Blood. 109, 12, p. 5136-5142 7 p.

Research output: Contribution to journalArticle

155 Scopus citations

Reply

Stopeck, A. T., Feb 2007, In : American Journal of Medicine. 120, 2

Research output: Contribution to journalArticle

2006

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.

Hayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A. T., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V. & Terstappen, L. W. W. M., Jul 15 2006, In : Clinical Cancer Research. 12, 14 Pt 1, p. 4218-4224 7 p.

Research output: Contribution to journalArticle

686 Scopus citations

Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer

Budd, G. T., Cristofanilli, M., Ellis, M. J., Stopeck, A. T., Borden, E., Miller, M. C., Matera, J., Repollet, M., Doyle, G. V., Terstappen, L. W. M. M. & Hayes, D. F., Nov 1 2006, In : Clinical Cancer Research. 12, 21, p. 6403-6409 7 p.

Research output: Contribution to journalArticle

554 Scopus citations

Erratum: A chilling tale (American Journal of Medicine (2005) 118 (1108-1110))

Stopeck, A. T., Feb 2006, In : American Journal of Medicine. 119, 2, p. 191 1 p.

Research output: Contribution to journalArticle

2005

Breast cancer prevention

Thompson, P. A. & Stopeck, A. T., 2005, Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, p. 347-385 39 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Breast cancer prevention

Thompson, P. A., Lopez, A. M. & Stopeck, A. T., 2005, Fundamentals of Cancer Prevention. Springer Berlin Heidelberg, p. 255-276 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Scopus citations

Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer

Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A. T., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., Fritsche, H. A., Hortobagyi, G. N. & Terstappen, L. W. M. M., 2005, In : Journal of Clinical Oncology. 23, 7, p. 1420-1430 11 p.

Research output: Contribution to journalArticle

791 Scopus citations

What happened to the coxibs on the way to the cardiologist?

Alberts, D. S., Potter, J. D., Martinez, M. E., Hess, L. M., Stopeck, A. T. & Lance, M. P., Mar 2005, In : Cancer Epidemiology Biomarkers and Prevention. 14, 3, p. 555-556 2 p.

Research output: Contribution to journalArticle

5 Scopus citations

Women's health: The struggle to restore hormonal balance

Stopeck, A. T., Nov 2005, In : American Journal of Medicine. 118, 11, p. 1181-1182 2 p.

Research output: Contribution to journalArticle

4 Scopus citations
2004

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy

Theilmann, R. J., Borders, R., Trouard, T. P., Xia, G., Outwater, E., Ranger-Moore, J., Gillies, R. J. & Stopeck, A. T., Nov 2004, In : Neoplasia. 6, 6, p. 831-837 7 p.

Research output: Contribution to journalArticle

209 Scopus citations

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A. T., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M. & Hayes, D. F., Aug 19 2004, In : New England Journal of Medicine. 351, 8, p. 781-791 11 p.

Research output: Contribution to journalArticle

2913 Scopus citations

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia

O'Farrell, A. M., Yuen, H. A., Smolich, B., Hannah, A. L., Louie, S. G., Hong, W., Stopeck, A. T., Silverman, L. R., Lancet, J. E., Karp, J. E., Albitar, M., Cherrington, J. M. & Giles, F. J., Jul 2004, In : Leukemia Research. 28, 7, p. 679-689 11 p.

Research output: Contribution to journalArticle

68 Scopus citations

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma

Zangari, M., Anaissie, E., Stopeck, A. T., Morimoto, A., Tan, N., Lancet, J., Cooper, M., Hannah, A., Garcia-Manero, G., Faderl, S., Kantarjian, H., Cherrington, J., Albitar, M. & Giles, F. J., Jan 1 2004, In : Clinical Cancer Research. 10, 1 I, p. 88-95 8 p.

Research output: Contribution to journalArticle

110 Scopus citations
2003

Phase II study of SU5416 - A small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor - In patients with refractory myeloproliferative diseases

Giles, F. J., Cooper, M. A., Silverman, L., Karp, J. E., Lancet, J. E., Zangari, M., Shami, P. J., Khan, K. D., Hannah, A. L., Cherrington, J. M., Thomas, D. A., Garcia-Manero, G., Albitar, M., Kantarjian, H. M. & Stopeck, A. T., Apr 15 2003, In : Cancer. 97, 8, p. 1920-1928 9 p.

Research output: Contribution to journalArticle

87 Scopus citations

SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

Giles, F. J., Stopeck, A. T., Silverman, L. R., Lancet, J. E., Cooper, M. A., Hannah, A. L., Cherrington, J. M., O'Farrell, A. M., Yuen, H. A., Louie, S. G., Hong, W., Cortes, J. E., Verstovsek, S., Albitar, M., O'Brien, S. M., Kantarjian, H. M. & Karp, J. E., Aug 1 2003, In : Blood. 102, 3, p. 795-801 7 p.

Research output: Contribution to journalArticle

175 Scopus citations
2002

Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast

Coronella, J. A., Perry, C. S., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H. & Hersh, E. M., Aug 15 2002, In : Journal of Immunology. 169, 4, p. 1829-1836 8 p.

Research output: Contribution to journalArticle

105 Scopus citations

Radial fast spin-echo method for T2-weighted imaging and T2 mapping of the liver

Altbach, M. I., Outwater, E. K., Trouard, T. P., Krupinski, E. A., Theilmann, R. J., Stopeck, A. T., Kono, M. & Gmitro, A. F., 2002, In : Journal of Magnetic Resonance Imaging. 16, 2, p. 179-189 11 p.

Research output: Contribution to journalArticle

49 Scopus citations

Results of a phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies

Stopeck, A. T., Sheldon, M., Vahedian, M., Cropp, G., Gosalia, R. & Hannah, A., Sep 2002, In : Clinical Cancer Research. 8, 9, p. 2798-2805 8 p.

Research output: Contribution to journalArticle

139 Scopus citations
2001

Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanoma

Stopeck, A. T., Jones, A., Hersh, E. M., Thompson, J. A., Finucane, D. M., Gutheil, J. C. & Gonzalez, R., 2001, In : Clinical Cancer Research. 7, 8, p. 2285-2291 7 p.

Research output: Contribution to journalArticle

108 Scopus citations
2000

Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft

Clark, P. R., Stopeck, A. T., Parker, S. E. & Hersh, E. M., Sep 15 2000, In : Cellular Immunology. 204, 2, p. 96-104 9 p.

Research output: Contribution to journalArticle

5 Scopus citations